Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 1
Results: 36
Bernard Fisher: A Pioneer Moves On.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 89, doi. 10.1634/theoncologist.2019-0884
- By:
- Publication type:
- Article
Twenty‐Five Years of The Oncologist.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 1, doi. 10.1634/theoncologist.2019-0883
- By:
- Publication type:
- Article
Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 15, doi. 10.1634/theoncologist.2019-0739
- By:
- Publication type:
- Article
Emmanuel Levinas: A Doctrine for Doctors.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 87, doi. 10.1634/theoncologist.2019-0823
- By:
- Publication type:
- Article
Supervised, Multimodal Exercise: The Chemotherapy Supportive Therapy That Almost Does It All.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 3, doi. 10.1634/theoncologist.2019-0628
- By:
- Publication type:
- Article
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e170, doi. 10.1634/theoncologist.2019-0370
- By:
- Publication type:
- Article
Use of High‐Cost Cancer Treatments in Academic and Nonacademic Practice.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 46, doi. 10.1634/theoncologist.2019-0338
- By:
- Publication type:
- Article
Guillain‐Barré Syndrome During Platinum‐Based Chemotherapy: A Case Series and Review of the Literature.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e194, doi. 10.1634/theoncologist.2019-0255
- By:
- Publication type:
- Article
Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e75, doi. 10.1634/theoncologist.2019-0240
- By:
- Publication type:
- Article
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e147, doi. 10.1634/theoncologist.2019-0244
- By:
- Publication type:
- Article
Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population‐Based Study.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e24, doi. 10.1634/theoncologist.2019-0412
- By:
- Publication type:
- Article
Real‐World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e109, doi. 10.1634/theoncologist.2019-0229
- By:
- Publication type:
- Article
Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta‐Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e94, doi. 10.1634/theoncologist.2019-0406
- By:
- Publication type:
- Article
Axicabtagene Ciloleucel, an Anti‐CD19 Chimeric Antigen Receptor T‐Cell Therapy for Relapsed or Refractory Large B‐Cell Lymphoma: Practical Implications for the Community Oncologist.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e138, doi. 10.1634/theoncologist.2019-0395
- By:
- Publication type:
- Article
Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 78, doi. 10.1634/theoncologist.2019-0365
- By:
- Publication type:
- Article
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e186, doi. 10.1634/theoncologist.2019-0221
- By:
- Publication type:
- Article
Potential Life‐Years Lost: The Impact of the Cancer Drug Regulatory and Funding Process in Canada.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e130, doi. 10.1634/theoncologist.2019-0314
- By:
- Publication type:
- Article
Cost and Utilization of Lung Cancer End‐of‐Life Care Among Racial‐Ethnic Minority Groups in the United States.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e120, doi. 10.1634/theoncologist.2019-0303
- By:
- Publication type:
- Article
Regorafenib in Combination with First‐Line Chemotherapy for Metastatic Esophagogastric Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e68, doi. 10.1634/theoncologist.2019-0492
- By:
- Publication type:
- Article
The Oncology Data Network (ODN): A Collaborative European Data‐Sharing Platform to Inform Cancer Care.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e1, doi. 10.1634/theoncologist.2019-0337
- By:
- Publication type:
- Article
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e48, doi. 10.1634/theoncologist.2019-0361
- By:
- Publication type:
- Article
Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor‐Positive/Androgen Receptor‐Positive Advanced Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 21, doi. 10.1634/theoncologist.2019-0564
- By:
- Publication type:
- Article
Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 19, doi. 10.1634/theoncologist.2019-0565
- By:
- Publication type:
- Article
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 23, doi. 10.1634/theoncologist.2019-0262
- By:
- Publication type:
- Article
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e16, doi. 10.1634/theoncologist.2019-0123
- By:
- Publication type:
- Article
An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e60, doi. 10.1634/theoncologist.2018-0905
- By:
- Publication type:
- Article
Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e85, doi. 10.1634/theoncologist.2019-0241
- By:
- Publication type:
- Article
Ambulation Recovery After Surgery for Metastases to the Femur.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e178, doi. 10.1634/theoncologist.2019-0107
- By:
- Publication type:
- Article
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e160, doi. 10.1634/theoncologist.2019-0297
- By:
- Publication type:
- Article
Diagnosis and Management of Rare Immune‐Related Adverse Events.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 6, doi. 10.1634/theoncologist.2019-0083
- By:
- Publication type:
- Article
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 33, doi. 10.1634/theoncologist.2019-0176
- By:
- Publication type:
- Article
The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e39, doi. 10.1634/theoncologist.2018-0528
- By:
- Publication type:
- Article
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 55, doi. 10.1634/theoncologist.2019-0160
- By:
- Publication type:
- Article
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5‐Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG‐ACRIN Cancer Research Group (E2205)
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e53, doi. 10.1634/theoncologist.2018-0750
- By:
- Publication type:
- Article
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 64, doi. 10.1634/theoncologist.2019-0027
- By:
- Publication type:
- Article
Prognostic Values of Long Noncoding RNA linc00152 in Various Carcinomas: An Updated Systematic Review and Meta‐Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e31, doi. 10.1634/theoncologist.2018-0358
- By:
- Publication type:
- Article